Skip to main content
. 2014 Oct 7;64(14):1452–1460. doi: 10.1016/j.jacc.2014.03.063

Table 5.

Improvement of Discrimination (C-Statistics) of 10-Year Risk Estimates for Addition of Growth Hormone to a Model With Conventional Cardiovascular Risk Factors

Outcome Sex Basic (95% CI) +GH (95% CI)
CAD All 0.748 (0.726–0.771) 0.749 (0.726–0.772)
Male 0.696 (0.665–0.726) 0.698 (0.667–0.729)
Female 0.744 (0.707–0.782) 0.744 (0.707–0.782)
Stroke All 0.753 (0.726–0.780) 0.757 (0.730–0.784)
Male 0.745 (0.708–0.781) 0.749 (0.712–0.785)
Female 0.749 (0.709–0.789) 0.752 (0.713–0.791)
CHF All 0.782 (0.739–0.825) 0.786 (0.743–0.828)
Male 0.784 (0.725–0.845) 0.784 (0.724–0.844)
Female 0.789 (0.724–0.853) 0.801 (0.737–0.865)
Total mortality All 0.711 (0.691–0.730) 0.714 (0.695–0.734)
Male 0.700 (0.673–0.727) 0.709 (0.683–0.736)
Female 0.703 (0.674–0.732) 0.703 (0.674–0.733)
Cardiovascular mortality All 0.783 (0.752–0.814) 0.794 (0.763–0.825)
Male 0.751 (0.705–0.797) 0.764 (0.719–0.809)
Female 0.797 (0.751–0.844) 0.807 (0.760–0.854)

Harrell’s c-statistic. Area under the receiver-operating characteristics curve in basic model without hs-GH (basic) and the basic model with addition of hs-GH (+GH). Variables included in the original model: sex, age, systolic blood pressure, body mass index, antihypertensive medication, current smoking, diabetes mellitus, LDL-C, and HDL-C.

Abbreviations as in Table 1, Table 3.